重新评估PTEN作为ADP-ribosylated坦基拉酶结合伙伴
Chiara Bosetti1, Albert Galera-Prat1, Anette Schmidt1
1Faculty of Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, Finland.
The FEBS journal
|February 24, 2025
概括
这项研究发现,PTEN与坦基拉斯没有直接相互作用,也没有受到坦基拉斯的修饰,这挑战了以前关于它们关系的假设. 这澄清了坦基酶抑制可能不会影响用于癌症治疗的PTEN水平.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 坦基拉酶是调节蛋白相互作用的酶,通过ADP-ribosylation起作用.
- PTEN是一种瘤抑制蛋白质,涉及各种癌症.
- 以前的研究表明,PTEN是坦基拉酶的基质和结合伙伴,具有潜在的治疗意义.
研究的目的:
- 为了研究和验证坦基拉酶和PTEN之间的相互作用.
- 为了确定PTEN是否是坦基拉酶介导ADP-ribosylation的直接基质.
- 为了澄清坦基拉酶抑制和PTEN蛋白水平之间的关系.
主要方法:
- 下拉测试用于测试蛋白质复合体的形成.
- 在体外ADP-ribosylation测试以评估酶活性.
- 对PTEN的假设坦基拉酶结合基因 (pTBM) 的进化分析.
- 在坦基拉酶抑制后对PTEN内源蛋白水平的分析.
主要成果:
- 在PTEN中假设的TBM不会与坦基拉斯-安基林重复集群域 (ARC) 结合.
- 进化分析表明,pTBM早于坦基拉斯.
- 实验室检测证实PTEN不会与坦基拉酶形成复合体,也不会经历ADP-ribosylation.
- 坦基拉酶的催化抑制没有影响内源PTEN蛋白水平.
结论:
- PTEN不是坦基拉斯的直接结合伙伴或基质.
- 以前提出的相互作用和调节机制没有得到实验证据的支持.
- 这一发现排除了PTEN和tankyrases之间的直接调节联系,影响了针对这种相互作用的潜在治疗策略.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
01:26Receptor Tyrosine Kinases
12.1K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.1K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K